DCF fair value estimate for Tectonic Therapeutic: $14.
Get informed when a big investor buys or sells
+ Follow$13.78
Overvalued by 55.2% based on the discounted cash flow analysis.
Tectonic Therapeutic (TECX) currently reports a DCF fair value of $14. Use the charts on this page to explore Tectonic Therapeutic's DCF fair value history and peer comparisons.
Tectonic Therapeutic's discounted cash flow (DCF) fair value estimate is $14, about 55.2% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $14, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tectonic Therapeutic, and consider following TECX for alerts when major investors trade the stock.